GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Myriad Genetics, Inc. (MYGN) [hlAlert]

Myriad Genetics, Inc. uses gene-based medicine to develop therapeutic and molecular diagnostic products. They employ a variety of proprietary proteomic technologies to discover disease genes and
to understand the role these genes and their related proteins play in the onset and progression of disease. They have integrated these technologies using bioinformatics and robotics systems to conduct their research efforts on a high-throughput basis. This has enabled them to identify numerous proteins as targets for new drugs and molecular diagnostic tests.
( Total: 36 Current Stock Recommendations )
Myriad Genetics, Inc.   (36)
Sell Hold 39% Buy 50%
Related companies
China Biologic ...   (4)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (6)
Buy 100%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 40% Buy 40%
Salix ...   (31)
Hold 39% Buy 61%
Filter by Gains:   
  
Rating:
Buy MYGN
up 1.54 %

Rating:
Hold MYGN

Rating:
Buy MYGN
down 1.03 %

Rating:
Hold MYGN

Rating:
Hold MYGN
down 25.84 %

Rating:
Hold MYGN
up 21.42 %

Rating:
Hold MYGN
down 32.02 %

Rating:
Hold MYGN

Rating:
Hold MYGN

Rating:
Hold MYGN
down 40.88 %
Myriad Genetics, Inc. (MYGN) downgraded to Neutral by Mizuho
Monday,  Dec 30, 2013  9:25 AM ET

Rating:
Sell MYGN
down 32.02 %

Rating:
Hold MYGN

Rating:
Buy MYGN
up 21.42 %

Rating:
Sell MYGN
down 25.84 %

Rating:
Sell MYGN
down 33.58 %

Your Recent Stocks
SymbolLastChange
MYGN 34.34 down  -3.15 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy